Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab in hospitalized COVID-19 pneumonia (Japan, Phase 3)
jRCT2080225157Phase 3Completed
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in coronavirus pneumonia comparing Sarilumab + usual hospital care with Placebo + usual hospital care (2 arms). Started Apr 2020; status: completed.
02
Drugs
sarilumab
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on jRCT2080225157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225157.